The latest labor trends in healthcare
Many providers continue to struggle with burned-out staff, high turnover and heightened labor costs. Disputes between hospitals and workers are likely to continue — a source of friction that could leave patients caught in the middle.

Millions of dollars in high-cost medications were going unused or expiring at Texas Children’s Hospital -- until a new approach to inventory visibility transformed pharmacy operations.

Learn how health plans and providers can overcome interoperability barriers, automate connectivity across disparate systems, and scale multi-point data exchange to improve operational efficiency, care collaboration, and workflow efficiency.

Across medical, dental, and veterinary practices, providers are sending a clear message: they want robust financial workflows built directly into the software they use every day. For software platforms, this shift represents a critical opportunity to transition your software from a simple workflow tool into an indispensable financial System of Record.

Payers and providers have always had to work with each other in healthcare. As M&A intensifies and companies are more likely to embrace more holistic and value-based care models, the partnerships have become more closely intertwined.

Payers and providers have always had to work with each other in healthcare. As M&A intensifies and companies are more likely to embrace more holistic and value-based care models, the partnerships have become more closely intertwined.

With the hit of the Coronavirus crisis, the acute need for interoperable health IT infrastructure in the U.S has become more apparent than ever. However, although industry supports interoperability in theory, pursuit of the goal threatens entrenched interests for payers, providers and health IT companies.

Data is vital to every life science company. The top 10 global life science organizations (by revenue) spend more than $100 million per year on data investments, and nearly the same amount on analytics, reporting, and data science. While this industry requires a unique data framework to manage regulatory, privacy, and compliance rules and regulations, most life science companies do not have a cohesive, organization-wide approach to managing their data.

Drug pricing reform in the U.S. is both further along than it’s been in years and stuck facing the same long odds that have frustrated past attempts at a major federal overhaul. If recent actions from Congress and the White House are any indication, pricing looks set to remain pharma’s greatest reputational risk of 2022 and beyond.

The pandemic’s long-term effect of widening previously existing gaps in care has exacerbated disparities in social determinants of health. A substantial portion of people who delayed or missed life-saving screenings during the pandemic, still have not gotten the pre-emptive healthcare they need. This has public health experts and medical practitioners concerned about the significant repercussions these missed screenings will have over time.

Learn how leading genomics organizations including Illumina, DNAnexus, GRAIL, and Genomics England leverage AWS for Genomics to optimize operations, safeguard data, and elastically scale to navigate ebbs and flows.

The “new normal.” It’s an overused phrase, but it’s a reality. The pandemic changed a lot about the ways we work, live and care for ourselves and each other. In healthcare, it meant a significant shift to virtual care whenever possible.